IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.400
+0.010 (0.72%)
At close: Oct 7, 2026, 4:00 PM EDT
1.410
+0.010 (0.71%)
After-hours: Oct 7, 2026, 5:00 PM EDT
IN8bio Employees
IN8bio had 18 employees as of June 30, 2026. The number of employees did not change compared to the same quarter last year. That makes IN8bio the world's 38,523rd largest employer and 5,589th in the United States.
Employees
18
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,037,056
Market Cap
13.80M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 18 | 0 | - |
| Mar 31, 2026 | 18 | 0 | - |
| Dec 31, 2025 | 17 | -1 | -5.56% |
| Sep 30, 2025 | 17 | -1 | -5.56% |
| Jun 30, 2025 | 18 | -21 | -53.85% |
| Mar 31, 2025 | 18 | -16 | -47.06% |
| Dec 31, 2024 | 18 | -13 | -41.94% |
| Sep 30, 2024 | 18 | -13 | -41.94% |
| Jun 30, 2024 | 39 | 10 | 34.48% |
| Mar 31, 2024 | 34 | 6 | 21.43% |
| Dec 31, 2023 | 31 | 5 | 19.23% |
| Sep 30, 2023 | 31 | 5 | 19.23% |
| Jun 30, 2023 | 29 | 8 | 38.10% |
| Mar 31, 2023 | 28 | 7 | 33.33% |
| Dec 31, 2022 | 26 | 7 | 36.84% |
| Sep 30, 2022 | 26 | 13 | 100.00% |
| Jun 30, 2022 | 21 | 7 | 50.00% |
| Mar 31, 2022 | 21 | 7 | 50.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Pluri | 113 |
| Passage Bio | 24 |
| Daré Bioscience | 24 |
| BioLineRx | 24 |
| Citius Pharmaceuticals | 23 |
| Tvardi Therapeutics | 12 |
| AEON Biopharma | 8 |
INAB News
- 1 day ago - IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 13 days ago - IN8bio Transcript: Small-Cap Virtual Conference - Transcripts
- 15 days ago - IN8bio to Present at Sidoti Small-Cap Virtual Conference - GlobeNewsWire
- 23 days ago - IN8bio Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 23 days ago - IN8bio Slides: Corporate presentation - Filings
- 27 days ago - IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 4 weeks ago - IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development - GlobeNewsWire
- 2 months ago - IN8bio reports Q2 EPS (25c), consensus (37c) - TheFly